- Home
- GFL vs ASND Comparison
GFL vs ASND Comparison
Compare GFL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GFL | ASND |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 15.2B |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GFL | ASND |
|---|---|---|
| Price | $39.63 | $260.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | $55.22 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 2.9M | 704.2K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.18 | $96.35 |
| Revenue Next Year | $7.20 | $44.91 |
| P/E Ratio | $5.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.33 | $161.09 |
| 52 Week High | $51.51 | $282.15 |
Technical Indicators
Market Signals| Indicator | GFL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 55.04 |
| Support Level | $38.60 | $213.28 |
| Resistance Level | $45.94 | $282.15 |
| Average True Range (ATR) | 1.18 | 8.03 |
| MACD | 0.07 | -0.92 |
| Stochastic Oscillator | 65.99 | 15.77 |
Price Performance
Historical ComparisonAbout GFL GFL Environmental Inc. Subordinate voting shares no par value
GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.